Nevro Corp. They provide a comprehensive range of products and services designed to address individualized pain management needs. One of their flagship products is the HFX iQ, an FDA-approved, AI-based pain management system.

Utilizing the largest clinical SCS dataset, it recommends personalized treatment programs to maximize pain relief and adjusts therapy based on patient responses. Nevro also offers the HFX system for specific indications such as painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP). With a focus on meaningful evidence and advanced therapies, Nevro ensures that patients receive tailored support and services for long-term pain relief.

Providers can rely on Nevro for the latest technological advancements and patient-focused care. Stay informed with the latest news and outcomes from Nevro, and explore how their comprehensive SCS solution can offer you the best chance at managing chronic pain effectively